An On-Site Follow-Up Assessment for Infants in the WIND35 Study.

Infant specific-IgE, rhinovirus-C bronchiolitis, and incident asthma in MARC-35

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Parrimon, Yozandra; Tilme, Linda

    Trial Phone: 321.841.1361 ; 321.843.5278

  • IRB No: 15.093.07

    Protocol Abbrev: MARC35 42-MONTH

    Principal Investigator: Federico Ricardo Laham, MD

    Age Group: Pediatric